# Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants

> **NCT05952076** · PHASE3 · TERMINATED · sponsor: **Gates Medical Research Institute** · enrollment: 40 (actual)

## Conditions studied

- Underweight
- Paediatrics

## Interventions

- **DIETARY_SUPPLEMENT:** B. infantis Bi-26
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05952076
- **Lead sponsor:** Gates Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-07-03
- **Primary completion:** 2023-12-26
- **Final completion:** 2024-01-29
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05952076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05952076, "Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05952076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*